Modelling SARS-CoV-2 unreported cases in Italy: Analysis of serological survey and vaccination scenarios

Objectives: Aim of the present paper is the study of the large unreported component, characterizing the SARS-CoV-2 epidemic event in Italy, taking advantage of the Istat survey. Particular attention is devoted to the sensitivity and specificity of the serological test and their effects. Methods: The...

Full description

Bibliographic Details
Main Authors: Marco Claudio Traini, Carla Caponi, Riccardo Ferrari, Giuseppe Vittorio De Socio
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2021-01-01
Series:Infectious Disease Modelling
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468042721000415
_version_ 1827279488785842176
author Marco Claudio Traini
Carla Caponi
Riccardo Ferrari
Giuseppe Vittorio De Socio
author_facet Marco Claudio Traini
Carla Caponi
Riccardo Ferrari
Giuseppe Vittorio De Socio
author_sort Marco Claudio Traini
collection DOAJ
description Objectives: Aim of the present paper is the study of the large unreported component, characterizing the SARS-CoV-2 epidemic event in Italy, taking advantage of the Istat survey. Particular attention is devoted to the sensitivity and specificity of the serological test and their effects. Methods: The model satisfactory reproduces the data of the Italian survey showing a relevant predictive power and relegating in a secondary position models which do not include, in the simulation, the presence of asymptomatic groups. The corrections due to the serological test sensitivity (in particular those ones depending on the symptoms onset) are crucial for a realistic analysis of the unreported (and asymptomatic) components. Results: The relevant presence of an unreported component during the second pandemic wave in Italy is confirmed and the ratio of reported to unreported cases is predicted to be roughly 1:4 in the last months of year 2020. A method to correct the serological data on the basis of the antibody sensitivity is suggested and systematically applied. The asymptomatic component is also studied in some detail and its amount quantified. A model analyses of the vaccination scenarios is performed confirming the relevance of a massive campaign (at least 80000 immunized per day) during the first six months of the year 2021, to obtain important immunization effects within August/September 2021.
first_indexed 2024-04-24T08:19:47Z
format Article
id doaj.art-e646e0eb0c084ba2bd604115b27324f8
institution Directory Open Access Journal
issn 2468-0427
language English
last_indexed 2024-04-24T08:19:47Z
publishDate 2021-01-01
publisher KeAi Communications Co., Ltd.
record_format Article
series Infectious Disease Modelling
spelling doaj.art-e646e0eb0c084ba2bd604115b27324f82024-04-17T01:58:21ZengKeAi Communications Co., Ltd.Infectious Disease Modelling2468-04272021-01-016909923Modelling SARS-CoV-2 unreported cases in Italy: Analysis of serological survey and vaccination scenariosMarco Claudio Traini0Carla Caponi1Riccardo Ferrari2Giuseppe Vittorio De Socio3Dipartimento di Fisica, Università Degli Studi di Trento, Via Sommarive 14, I-38123, Trento-Povo, Italy; Corresponding author.Clinica Geriatrica, Azienda Ospedaliero-Universitaria, Piazzale Gambuli 1, 06132, Perugia, ItalyBilubah LLC, 30 N. Gould St, Suite 6739, Sheridan, WY, 82801, USAClinica Malattie Infettive, Azienda Ospedaliero-Universitaria, Piazzale Gambuli 1, 06132, Perugia, ItalyObjectives: Aim of the present paper is the study of the large unreported component, characterizing the SARS-CoV-2 epidemic event in Italy, taking advantage of the Istat survey. Particular attention is devoted to the sensitivity and specificity of the serological test and their effects. Methods: The model satisfactory reproduces the data of the Italian survey showing a relevant predictive power and relegating in a secondary position models which do not include, in the simulation, the presence of asymptomatic groups. The corrections due to the serological test sensitivity (in particular those ones depending on the symptoms onset) are crucial for a realistic analysis of the unreported (and asymptomatic) components. Results: The relevant presence of an unreported component during the second pandemic wave in Italy is confirmed and the ratio of reported to unreported cases is predicted to be roughly 1:4 in the last months of year 2020. A method to correct the serological data on the basis of the antibody sensitivity is suggested and systematically applied. The asymptomatic component is also studied in some detail and its amount quantified. A model analyses of the vaccination scenarios is performed confirming the relevance of a massive campaign (at least 80000 immunized per day) during the first six months of the year 2021, to obtain important immunization effects within August/September 2021.http://www.sciencedirect.com/science/article/pii/S2468042721000415ARS-CoV-2Asymptomatic and unreported casesSeroprevalenceEpidemiological modelsSensitivity and specificity of the serological testsVaccination
spellingShingle Marco Claudio Traini
Carla Caponi
Riccardo Ferrari
Giuseppe Vittorio De Socio
Modelling SARS-CoV-2 unreported cases in Italy: Analysis of serological survey and vaccination scenarios
Infectious Disease Modelling
ARS-CoV-2
Asymptomatic and unreported cases
Seroprevalence
Epidemiological models
Sensitivity and specificity of the serological tests
Vaccination
title Modelling SARS-CoV-2 unreported cases in Italy: Analysis of serological survey and vaccination scenarios
title_full Modelling SARS-CoV-2 unreported cases in Italy: Analysis of serological survey and vaccination scenarios
title_fullStr Modelling SARS-CoV-2 unreported cases in Italy: Analysis of serological survey and vaccination scenarios
title_full_unstemmed Modelling SARS-CoV-2 unreported cases in Italy: Analysis of serological survey and vaccination scenarios
title_short Modelling SARS-CoV-2 unreported cases in Italy: Analysis of serological survey and vaccination scenarios
title_sort modelling sars cov 2 unreported cases in italy analysis of serological survey and vaccination scenarios
topic ARS-CoV-2
Asymptomatic and unreported cases
Seroprevalence
Epidemiological models
Sensitivity and specificity of the serological tests
Vaccination
url http://www.sciencedirect.com/science/article/pii/S2468042721000415
work_keys_str_mv AT marcoclaudiotraini modellingsarscov2unreportedcasesinitalyanalysisofserologicalsurveyandvaccinationscenarios
AT carlacaponi modellingsarscov2unreportedcasesinitalyanalysisofserologicalsurveyandvaccinationscenarios
AT riccardoferrari modellingsarscov2unreportedcasesinitalyanalysisofserologicalsurveyandvaccinationscenarios
AT giuseppevittoriodesocio modellingsarscov2unreportedcasesinitalyanalysisofserologicalsurveyandvaccinationscenarios